Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316633 | SCV000666763 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-07-17 | criteria provided, single submitter | clinical testing | The p.A797V variant (also known as c.2390C>T), located in coding exon 20 of the NF1 gene, results from a C to T substitution at nucleotide position 2390. The alanine at codon 797 is replaced by valine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000706982 | SCV000836058 | benign | Neurofibromatosis, type 1 | 2024-09-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001755935 | SCV002005665 | uncertain significance | not provided | 2023-08-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25486365) |
Genome- |
RCV000706982 | SCV002562036 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |